mGluR1-expressing iMMECs showed elevated levels of extracellular glutamate, and inclusion of a glutamate release inhibitor, riluzole, reduced cell growth in vitro and tumor progression in MCF7 xenografts in vivo [101]. The gene discussed is GRM1; the disease is neoplasm.